Contribution: Industrial Research Assistance Program – Contributions to Firms
Bioscision Pharma Inc.
$0.00
Bringing Animal Health Drug Manufacturing to Manitoba
EF 2025-26 · 2025-07-28
Résumé
BioScision Pharma operates in a 65,000 SF drug manufacturing facility in Winnipeg Manitoba. BioScision will leverage its advanced drug manufacturing facility and experience to begin formulating, compounding, filling, finishing and testing, and distributing in-demand off-patent essential animal health drugs.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Winnipeg|Winnipeg, Manitoba, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
730637519
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2025-07-28 | 2025-26 | $120,000.00 |
| 1 | 2025-07-28 | 2025-26 | $0.00 |
Tel que publié
Agreement End Date
2026-09-30
Agreement Number
1033986
Agreement Start Date
2025-07-28
Agreement Title
Bringing Animal Health Drug Manufacturing to Manitoba
Agreement Title (French)
La fabrication de médicaments pour la santé animale au Manitoba
Agreement Type
Contribution
Agreement Value
$0.00
Amendment Date
2026-07-01
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
BioScision Pharma operates in a 65,000 SF drug manufacturing facility in Winnipeg Manitoba. BioScision will leverage its advanced drug manufacturing facility and experience to begin formulating, compounding, filling, finishing and testing, and distributing in-demand off-patent essential animal health drugs.
Description (French)
BioScision Pharma exploite une installation de fabrication de médicaments de 65 000 pieds carrés à Winnipeg, au Manitoba. BioScision tirera parti de son installation de fabrication de pointe et de son expérience pour commencer à formuler, à composer, à remplir, à finir, à tester et à distribuer des médicaments essentiels pour la santé animale dont le brevet a expiré et qui sont très demandés.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Winnipeg South
Federal Riding (French)
Winnipeg-Sud
Federal Riding Number
46013
NAICS Code
311224
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
730637519
Recipient City
Winnipeg|Winnipeg
Recipient Country
CA
Recipient Legal Name
Bioscision Pharma Inc.
Recipient Operating Name
Bioscision
Recipient Postal Code
R3Y 1G4
Recipient Province or Territory
MB
Recipient Type
F
Reference Number
172-2025-2026-Q3-1033986
